DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Eiermann W, Rezai M, Kummel S et al.
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for
ER-positive, node-negative and node-positive early breast cancer resulting in a
risk-adapted change in chemotherapy use.
Ann Oncol 2013;
24: 618-624
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.